30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014 Revenue: Globus Medical

4Q14 revenue: $128.8MMM, +12% (U.S. +13%, ex-U.S. +10%)

2014 revenue: $474.4MM, +9% (U.S. $427.0MM, +8%; ex-U.S. $47.2MM, +25%)

  • Innovative Fusion $270.8MM, +7%
  • Disruptive Technology $203.5MM, +13%


Biologics +35%

Price pressure remained in mid-single-digits

Pronounced spike in procedures in late 4Q

Positive early feedback from 1st 250 ALTERA TLIF spacer surgeries

Will launch 9 more CREO systems in next 18 months; to date, CREO platform used in ~6,000 surgeries worldwide

Acquired Transplant Technologies of Texas, with active pipeline of multiple tissue-based products in various development stages to launch in 2015 and beyond to get biologics at 10%-15% of sales

In 1Q, announced plans to acquire Branch Medical (supplier) for $52.9MM in cash: ~50,000 sq. ft., 110 employees, 2014 revenue $23MM (Update in 2Q15: final purchase price was $68MM)

No big international launches slated for 2015

Planning 2016 commercialization of robotic surgical aid